Sobi’s pipeline programs are focused on recombinant protein drugs for specialist
indications for the global market.
Pipeline programs
| Indication |
Product/Project |
Partner |
Phase 1 |
Phase 2 |
Phase 3 |
REG Phase |
| Haemophilia A |
rFVIIIFc |
Biogen Idec |
|
|
|
|
| Haemophilia B |
rFIXFc |
Biogen Idec |
|
|
|
|
| Improve growth in preterm infants |
Kiobrina |
- |
|
|
|
|
Life cycle management initiatives
Activity
| Program |
Expected timing |
| Kiobrina® (improve growth): phase III data |
2014 |